CD40 expression in prostate cancer: A potential diagnostic and therapeutic molecule

Oncology Reports

Volumn 12, Issue 4, 2004, Pages 679-682

  Palmer, Daniel H ^a   Hussain, S A ^a   Ganesan, R ^a   Cooke, P W ^a   Wallace, D M A ^b   Young, L S ^a   James, N D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

CD40 expression; Prostate cancer; Tumour biology

Indexed keywords

CD40 ANTIGEN;

AGED; ARTICLE; CANCER INVASION; CANCER STAGING; COMPARATIVE STUDY; ENZYME IMMUNOASSAY; EPITHELIUM; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE HYPERTROPHY; PROSTATE TUMOR;

AGED; AGED, 80 AND OVER; ANTIGENS, CD40; EPITHELIUM; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 16644389621     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.4.679     Document Type: Article

References (22)

1. Paulie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H and Perlmann P: A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother 20: 23-28, 1985. (Pubitemid 15238919)
2. Van Kooten C and Banchereau J: Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Immunol 9: 330-337, 1997.
3. Banchereau J, Bazan F, Blanchard D, Briere F, Galizzi JP, van Kooten C, Liu YJ, Rousset F and Saeland S: The CD40 antigen and its ligand. Annu Rev Immunol 12: 881-922, 1994. (Pubitemid 24140434)
4. Eliopoulos AG, Dawson CW, Mosialos G, Floettmann JE, Rowe M, Armitage RJ, Dawson J, Zapata JM, Kerr DJ, Wakelam MJ, Reed JC, Kieff E and Young LS: CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13: 2243-2254, 1996. (Pubitemid 26411575)
5. Eliopoulos AG, Stack M, Dawson CW, Kaye KM, Hodgkin L, Sihota S, Rowe M and Young LS: Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors. Oncogene 14: 2899-2916, 1997. (Pubitemid 27315659)
6. Peguet-Navarro J, Dalbiez-Gauthier C, Mouion C, Berthier O, Reano A, Gaucherand M, Banchereau J, Rousset F and Schmitt D: CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J Immunol 158: 144-152, 1997. (Pubitemid 127483851)
7. Denfeld RW, Hollenbaugh D, Fehrenbach A, Weiss JM, Mai B, von Leoprechting A, Voith U, Schopf E, Aruffo A and Simon JC: CD40 is functionally expressed on human keratinocytes. Eur J Immunol 26: 2329-2334, 1996. (Pubitemid 26340931)
8. Gaspari AA, Sempowski GD, Chess P, Gish J and Phipps RP: Human epidermal keratinocytes are induced to secrete interleukin-6 and co-stimulate T lymphocyte proliferation by a CD40-dependent mechanism. Eur J Immunol 26: 1371-1377, 1996. (Pubitemid 26001075)
9. Agathanggelou A, Niedobitek G, Chen R, Nicholls J, Yin W and Young LS: Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells. Am J Pathol 147: 1152-1160, 1995.
10. Ghosh M, Crocker J and Morris AG: CD40 and Bcl2 expression in squamous cell carcinoma of the lung: correlation with apoptosis, survival, and other clinicopathological factors. J Pathol 189: 363-367, 1999. (Pubitemid 29489221)
11. Thomas WD, Smith MJ, Si Z and Hersey P: Expression of the co-stimulatory molecule CD40 on melanoma cells. Int J Cancer 68: 795-801, 1996. (Pubitemid 27062043)
12. Sugimoto K, Shiraki K, Ito T, Fujikawa K, Takase K, Tameda Y, Moriyama M and Nakano T: Expression of functional CD40 in human hepatocellular carcinoma. Hepatology 30: 920-926, 1999. (Pubitemid 29458280)
13. Gallagher NJ, Eliopoulos AG, Agathangelo A, Oates J, Crocker J and Young LS: CD40 activation in epithelial ovarian carcinoma cells modulates growth, apoptosis, and cytokine secretion. Mol Pathol 55: 110-120, 2002. (Pubitemid 34293413)
14. Davies CC, Mason J, Wakelam MJ, Eliopoulos AG and Young LS: Inhibition of phosphatidylinositol 3-kinase- and ERK MAPK-regulated protein synthesis reveals the proapoptotic properties of CD40 ligation in carcinoma cells. J Biol Chem 279: 1010-1019, 2004. (Pubitemid 38082622)
15. Cooke PW, James ND, Ganesan R, Wallace M, Burton A and Young LS: CD40 expression in bladder cancer. J Pathol 188: 38-43, 1999. (Pubitemid 29197312)
16. Hussain SA, Ganesan R, Hiller L, Murray PG, el-Magraby MM, Young L and James ND: Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder. Br J Cancer 88: 586-592, 2003. (Pubitemid 36363369)
17. Kluth B, Hess S, Engelmann H, Schafnitzel S, Riethmuller G and Feucht HE: Endothelial expression of CD40 in renal cell carcinoma. Cancer Res 57: 891-899, 1997. (Pubitemid 27098014)
18. Moghaddami M, Cohen P, Stapleton AM and Brown MP: CD40 is not detected on human prostate cancer cells by immunohistologic techniques. Urology 57: 573-578, 2001. (Pubitemid 32193003)
19. Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M and Weinberg A: Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J Immunol 158: 977-983, 1997.
20. Hirano A, Longo DL, Taub DD, Ferris DK, Young LS, Eliopoulos AG, Agathanggelou A, Cullen N, Macartney J, Fanslow WC and Murphy WJ: Inhibition of human breast carcinoma growth by a soluble recombinant human CD40 ligand. Blood 93: 2999-3007, 1999. (Pubitemid 29200792)
21. Vonderheide RH, Dutcher JP, Anderson JE, Eckhardt SG, Stephans KF, Razvillas B, Garl S, Butine MD, Perry VP, Armitage RJ, Ghalie R, Caron DA and Gribben JG: Phase I study of recombinant human CD40 ligand in cancer patients. J Clin Oncol 19: 3280-3287, 2001. (Pubitemid 32591446)
22. Alexandroff AB, Jackson AM, Paterson T, Haley JL, Ross JA, Longo DL, Murphy WJ, James K and Taub DD: Role for CD40-CD40 ligand interactions in the immune response to solid tumours. Mol Immunol 37: 515-26, 2000. (Pubitemid 32001693)